Tenderwize
Back to tender search

Finland – Pharmaceutical products – Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2027 + optiovuosi 2028 Pohjois-Pohjanmaan hyvinvointialueelle

Pohjois-Pohjanmaan hyvinvointialuePOHDE, FinlandNot disclosed9 days leftopen
30

Opportunity Score

Confidence: 40%

Complexity: medium

9 days

Deadline

supplies

Contract

Deep Portfolio Analysis

  • Company fit score
  • Missing certificates
  • Eligibility blockers
  • Bid / No-Bid recommendation
Create account for AI analysis

AI Analysis Summary

Moderate opportunity

This tender from Pohjois-Pohjanmaan hyvinvointialue (North Ostrobothnia welfare area) is for the supply of monoclonal antibodies and antibody-conjugated drugs (ATC group L01F) for the period 1.1.2027–31.12.2027 with an optional extension year (2028). The procedure is open, with electronic submission required via Kilpo.fi. The tender is awarded based on price (70%) and quality (30%). Only one lot is explicitly described in the structured data, but a second lot appears with incomplete information. No estimated value is provided. Submissions are accepted only in Finnish. The structured data includes two lots, but the XML notice references only one lot, indicating a potential extraction issue. No procurement documents beyond the notice were analyzed.

Strengths

Documents available

Open procedure

Medium complexity

Risks

Submission deadline in 9 days

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

  • Marketing authorization in Finland required by the start of the contract period.
  • Products must be commercially available in Finland by 1.1.2027.
  • Electronic submission via Kilpo.fi is mandatory.

Buyer

Name

Pohjois-Pohjanmaan hyvinvointialue

Location

POHDE, FIN

Identifier

3221326-2

Lots (2)

#LOT-0000Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2027 + optiovuosi 2028 Pohjois-Pohjanmaan hyvinvointialueelle

Procurement of monoclonal antibodies and antibody-conjugated drugs in ATC group L01F. Products must have marketing authorization in Finland and be commercially available by 1.1.2027. Products with ongoing authorization processes are eligible if completed before the start of the contract period.

33600000FIN

Lot information incomplete in structured data. Only award criteria (quality) provided; no description, CPV, or deadline available.

Procurement Details

Publication

21 May 2026

Deadline

24 Jun 2026, 12:00

Procedure

open

Contract

supplies

Duration

24 MONTH

Language

FIN

Publication #

351390-2026

Classification

Performance: Finland

Documents (2)

Monoclonal antibodies for North Os Tender in Finland | TED 351390-2026